Skip to content

Are Regulators Driving or Impeding Innovation in Clinical Trials?

Discover a groundbreaking webinar delving into regulatory innovations in clinical trials, assessing new tech compliance and enhancing data quality while reducing site and patient burdens. Innovation in clinical trials historically has been slow, and people often point to regulations and regulators as the reason. Are regulators truly the bottleneck? In this webinar, Jonathan Andrus makes the argument that regulators are actually a driving force behind innovation. This webinar will provide examples across the clinical trials process where regulators are not only supporting but encouraging innovation, including:

Study design — requesting patient input on protocols, using novel trial designs that reduce patient burden, advancing risk-based approaches

Study conduct — risk-based approaches to monitoring and study oversight, use of real-world evidence

Post-study — faster approvals and adaptive pathways, early access to promising treatments, expanded use of post-market surveillance

Internal quality assurance (QA) and regulatory teams can be a hold-up when they rely on historical practices and personal preference rather than current regulatory guidance in assessing the feasibility and risks of implementing new and innovative solutions to clinical trial challenges. It’s time for sponsors, contract research organizations (CROs) and technology vendors to step up and join the evolution of clinical data management to data science — a strategic discipline enabling the execution of complex protocol designs in a patient-centric, data-driven and risk-based approach to ensuring subject protection as well as the validity of trial results. This webinar will also include a real-life example of how CRIO used direct communication with regulators to resolve questions about the implementation of single sign-on (SSO) with electronic signatures — an area where previous regulatory guidance was ambiguous and predated the current infrastructure of SSO. Through these interactions, CRIO was able to achieve a path forward that is compliant, innovative and meets the needs of our clients.

Share this post
You may also find interesting
Explore our Blog
Partners Program Webinar

CRIO Partners Program Overview

This webinar provides an overview to the newly launched CRIO Partners Program and the highly anticipated Partner Directory! This 15 – minute session is designed to give you a quick yet comprehensive look at these exciting new additions to the CRIO platform.

Meganetwork CRIO Webinar

XTalks Webinar: Clinical Trial Sites: The Rise of the Meganetwork

Watch this on-demand webinar for a discussion of recent trends in clinical trial site network consolidation. The latest eBook, “The Rise of the Clinical Trial Site Mega Network” is the third installment in the “Scaling and Innovating” series by CRIO. In the first book in this series (published in 2019), CRIO predicted that clinical research...


eSource Challenges and Opportunities on the SCDM Podcast

Dr. Elena Christofides joins the SCDM podcast to talk with Linda King about the challenges and opportunities of using eSource from a site perspective. Dr. Christofides is an experienced global lead Principal Investigator with Endocrinology Associates, Inc. She has using eSource for more than a decade and shares some of the top challenges she has...

Get articles delivered to your inbox, every week